Investigating fatigue and cognitive dysfunction in patients after stem cell transplantation
Official title: Fatigue Och Kognitiv Dysfunktion Till följd av Synaptopati Eller Graft Versus Host (GVH) Sjukdom i hjärnan
Run by Karolinska Institutet · NCT06363396 · Data updated 2026-11-12
This study is trying to see if there are specific signs in the blood and spinal fluid that can help identify fatigue and thinking problems in patients who have had stem cell transplants.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | February 22, 2024 |
| Main results expected | February 22, 2026 |
| Study ends | February 22, 2027 |
| Registry record updated | April 12, 2024 |
| Trial ID | NCT06363396 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who are 1-5 years post-allogeneic stem cell transplantation without known CNS disorders or psychiatric disturbances.
✕Probably not a fit
Patients with prior CNS irradiation, known neurological or psychiatric disorders, or those less than 1 year or more than 5 years post-transplant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows patients who have undergone allogeneic stem cell transplantation to systematically measure fatigue and cognitive impairment using international standards. The study aims to validate previous findings regarding distinct mRNA and proteomic profiles that differentiate fatigued from non-fatigued patients. Researchers will analyze blood and cerebrospinal fluid samples to identify potential biomarkers for cognitive dysfunction and fatigue, employing advanced techniques such as mass spectrometry and Olink technology. Additionally, neurocognitive testing will be conducted to predict which patients may develop these conditions, contributing to a better understanding of their pathophysiology.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of fatigue and cognitive dysfunction in patients post-transplant.
How similar studies have gone: Previous studies have suggested distinct biological profiles related to fatigue and cognitive dysfunction, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * status 1-5 years after HSCT * no known CNS disorders or psychiatric disturbances Exclusion Criteria: * prior TBI or CNS irradiation / intrathecal therapy * known neurological or psychiatric disorder * time less then 1 year or over 5 years after transplantation
Where it's running
-
Karolinska
Stockholm, Sweden Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fatigue and thinking problems after allogeneic stem cell transplant (synapse damage or brain GVHD)
This project uses PET scans and spinal fluid samples to try to find why people who had an allogeneic stem cell transplant have persistent fatigue and thinking problems.
-
Sexual problems in women with relapsing-remitting multiple sclerosis
See if sexual dysfunction is common in women aged 25-50 with relapsing-remitting MS and whether it's linked to fatigue, mood, bladder symptoms, and cognitive problems.
-
Cognitive Function and Fatigue After Brain Abscess
This study is testing how brain abscesses affect thinking skills and tiredness in people who have had this condition.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.